Viphar - NXS.
Charlie Aitken (Southern Cross Equities) recomm. in this morning's newsletter.
"NXS is an undervalued asset play, which we conservatively value at $0.52. If management can execute a good deal on Crux, the valuation could
exceed $0.75. The company has re-capitalised and successfully commissioned the Longtom gas field, providing a solid cash flow base of $70 million pa
for the next ten years plus. We see very little downside risk from the current price level but a lot of upside potential."
- Forums
- ASX - Day Trading
- daytrade diaries... november 13
daytrade diaries... november 13, page-91
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online